Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery

Current Opinion in Pharmacology

Volumn 13, Issue 6, 2013, Pages 983-988

  Holst, Jens Juul ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; INSULIN; LEPTIN; PEPTIDE YY;

APPETITE; ARTICLE; BARIATRIC SURGERY; CALORIC RESTRICTION; DIABETES MELLITUS; ENTEROENDOCRINE CELL; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INTESTINE ABSORPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN FUNCTION; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; EATING; ENTEROENDOCRINE CELLS; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; HUMANS; OBESITY;

EID: 84888199705     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.09.014     Document Type: Review

References (59)

1. I. Imaz, C. Martinez-Cervell, E.E. Garcia-Alvarez, J.M. Sendra-Gutierrez, and J. Gonzalez-Enriquez Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis Obes Surg 18 2008 841 846
2. F.J. Verdam, P.R. Liedorp, and N. Geubbels EndoBarrier for counteracting obesity and metabolic syndrome Ned Tijdschr Geneeskd 156 2012 A3844
3. G. Ramsey-Stewart, and L. Martin Jaw wiring in the treatment of morbid obesity Aust N Z J Surg 55 1985 163 167 (Pubitemid 15003049)
4. H. Ashrafian, M. Bueter, and K. Ahmed Metabolic surgery: an evolution through bariatric animal models Obes Rev 11 2010 907 920
5. J. Kampe, A. Stefanidis, and S.H. Lockie Neural and humoral changes associated with the adjustable gastric band: insights from a rodent model Int J Obes (Lond) 36 2012 1403 1411
6. H. Buchwald, R. Estok, and K. Fahrbach Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am J Med 122 2009 248 256
7. T.I. Sorensen, K.B. Lauritsen, J.J. Holst, F. Stadil, and B. Andersen Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio Digestion 26 1983 137 145 (Pubitemid 13161994)
8. M. Moshiri, S. Osman, T.J. Robinson, S. Khandelwal, P. Bhargava, and C.A. Rohrmann Evolution of bariatric surgery: a historical perspective AJR Am J Roentgenol 201 2013 W40 W48
9. H. Buchwald, Y. Avidor, and E. Braunwald Bariatric surgery: a systematic review and meta-analysis JAMA 292 2004 1724 1737 (Pubitemid 39346675)
10. A.M. Carlin, T.M. Zeni, and W.J. English The comparative effectiveness of sleeve gastrectomy, gastric bypass, and adjustable gastric banding procedures for the treatment of morbid obesity Ann Surg 257 2013 791 797
11. H. Buchwald, R. Estok, K. Fahrbach, D. Banel, and I. Sledge Trends in mortality in bariatric surgery: a systematic review and meta-analysis Surgery 142 2007 621 632
12. Y. Falken, P.M. Hellstrom, J.J. Holst, and E. Naslund Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides J Clin Endocrinol Metab 96 2011 2227 2235
13. C. Dirksen, M. Damgaard, and K.N. Bojsen-Moller Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass Neurogastroenterol Motil 25 2013 e255 e346
14. O. Ziegler, M.A. Sirveaux, L. Brunaud, N. Reibel, and D. Quilliot Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies Diabetes Metab 35 2009 544 557
15. E.A. Odstrcil, J.G. Martinez, and C.A. Santa Ana The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass Am J Clin Nutr 92 2010 704 713
16. W.J. Pories, M.S. Swanson, and K.G. MacDonald Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 222 1995 339 350
17. C. Dirksen, N.B. Jorgensen, and K.N. Bojsen-Moller Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass Diabetologia 55 2012 1890 1901
18. N.B. Jorgensen, S.H. Jacobsen, and C. Dirksen Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance Am J Physiol Endocrinol Metab 303 2012 E122 E131
19. J.M. Isbell, R.A. Tamboli, and E.N. Hansen The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery Diabetes Care 33 2010 1438 1442
20. C. Jackness, W. Karmally, and G. Febres Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell function in Type 2 diabetic patients Diabetes 62 2013 3027 3032
21. E. Ferrannini, and G. Mingrone Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes Diabetes Care 32 2009 514 520
22. S.H. Jacobsen, K.N. Bojsen-Moller, and C. Dirksen Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals Diabetologia 56 2013 2250 2254
23. K.N. Bojsen-Moller, C. Dirksen, and N.B. Jorgensen Increased hepatic insulin clearance after Roux-en-Y gastric bypass J Clin Endocrinol Metab 98 2013 E1066 E1071
24. F.A. McAlister, J. Man, L. Bistritz, H. Amad, and P. Tandon Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes Diabetes Care 26 2003 1518 1524 (Pubitemid 36929189)
25. F. Rodieux, V. Giusti, D.A. D'Alessio, M. Suter, and L. Tappy Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release Obesity (Silver Spring) 16 2008 298 305 (Pubitemid 351271908)
26. S.H. Jacobsen, S.C. Olesen, and C. Dirksen Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects Obes Surg 22 2012 1084 1096
27. J.J. Holst The physiology of glucagon-like peptide 1 Physiol Rev 87 2007 1409 1439 (Pubitemid 350041474)
28. M.A. Cohen, S.M. Ellis, and C.W. Le Roux Oxyntomodulin suppresses appetite and reduces food intake in humans J Clin Endocrinol Metab 88 2003 4696 4701 (Pubitemid 37357514)
29. J.L. Estall, and D.J. Drucker Glucagon-like peptide-2 Annu Rev Nutr 26 2006 391 411
30. R.L. Batterham, H. Heffron, and S. Kapoor Critical role for peptide YY in protein-mediated satiation and body-weight regulation Cell Metab 4 2006 223 233 (Pubitemid 44307976)
31. C.W. Le Roux, R. Welbourn, and M. Werling Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass Ann Surg 246 2007 780 785 (Pubitemid 350035654)
32. C. Dirksen, N.B. Jorgensen, and K.N. Bojsen-Moller Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypassRef 32: Int J Obes (Lond) 2013 10.1038/ijo.2013.15
33. L.L. Kjems, J.J. Holst, A. Volund, and S. Madsbad The influence of GLP-1 on the glucose-induced insulin secretion: effects on beta cell sensitivity in type 2 diabetic patients and controls Diabetes 52 2003 380 386 (Pubitemid 36173193)
34. N.B. Jorgensen, C. Dirksen, and K.N. Bojsen-Moller Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes Diabetes 62 2013 3044 3052
35. E. Naslund, P. Gryback, and P.M. Hellstrom Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity Int J Obes Relat Metab Disord 21 1997 387 392 (Pubitemid 27190191)
36. D.E. Cummings Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery Int J Obes (Lond) 33 Suppl. 1 2009 S33 S40
37. P. Bjorklund, A. Laurenius, E. Een, T. Olbers, H. Lonroth, and L. Fandriks Is the Roux limb a determinant for meal size after gastric bypass surgery? Obes Surg 20 2010 1408 1414
38. P.L. Jansen, W.J. van, and E. Aarts Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery Dig Dis 29 2011 48 51
39. K.K. Ryan, B. Li, B.E. Grayson, E.K. Matter, S.C. Woods, and R.J. Seeley A role for central nervous system PPAR-gamma in the regulation of energy balance Nat Med 17 2011 623 626
40. N.M. Neary, C.J. Small, and M.R. Druce Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively Endocrinology 146 2005 5120 5127 (Pubitemid 41653025)
41. J. Korner, M. Bessler, W. Inabnet, C. Taveras, and J.J. Holst Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding Surg Obes Relat Dis 3 2007 597 602
42. N. Geary Pancreatic glucagon signals postprandial satiety Neurosci Biobehav Rev 14 1990 323 338 (Pubitemid 20266413)
43. G. Mingrone, G. Nolfe, and G.C. Gissey Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion Diabetologia 52 2009 873 881
44. F. Romero, J. Nicolau, and L. Flores Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects Surg Endosc 26 2012 2231 2239
45. V.N. Trung, H. Yamamoto, and A. Furukawa Enhanced intestinal motility during oral glucose tolerance test after laparoscopic sleeve gastrectomy: preliminary results using cine magnetic resonance imaging PLoS One 8 2013 e65739
46. S. Liu, G. Zhang, and L. Wang The entire small intestine mediates the changes in glucose homeostasis after intestinal surgery in Goto-Kakizaki rats Ann Surg 256 2012 1049 1058
47. A.P. Chambers, L. Jessen, and K.K. Ryan Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats Gastroenterology 141 2011 950 958
48. H.E. Wilson-Perez, A.P. Chambers, and K.K. Ryan Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency Diabetes 62 2013 2380 2385
49. M. Bueter, C. Lowenstein, and T. Olbers Gastric bypass increases energy expenditure in rats Gastroenterology 138 2010 1845 1853
50. S.K. Das, S.B. Roberts, and M.A. McCrory Long-term changes in energy expenditure and body composition after massive weight loss induced by gastric bypass surgery Am J Clin Nutr 78 2003 22 30 (Pubitemid 39655244)
51. C. Verdich, S. Toubro, B. Buemann, M.J. Lysgard, H.J. Juul, and A. Astrup The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction Int J Obes Relat Metab Disord 25 2001 1206 1214 (Pubitemid 32721544)
52. N. Matikainen, L.H. Bogl, and A. Hakkarainen GLP-1 responses are heritable and blunted in acquired obesity with high liver fat and insulin resistance Diabetes Care 2013 PMID: 23990519
53. M. Nauck, W.E. Schmidt, and R. Ebert Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8 J Clin Endocrinol Metab 69 1989 654 662 (Pubitemid 19221242)
54. M. Nauck, F. Stockmann, R. Ebert, and W. Creutzfeldt Reduced incretin effect in type 2 (non-insulin-dependent) diabetes Diabetologia 29 1986 46 52 (Pubitemid 16162741)
55. M.B. Toft-Nielsen, M.B. Damholt, and S. Madsbad Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients J Clin Endocrinol Metab 86 2001 3717 3723 (Pubitemid 32755966)
56. P. Hojbjerg, T. Vilsboll, F.K. Knop, M. Bache, S. Madsbad, T. Krarup, and J.J. Holst Four weeks of near-normalizatioin of blood glucose restores the insulin response to GIP and improves the insulin response to GLP-1 in patients with type 2 diabetes Diabetes 56 2007 A373 (Abstract)
57. T. Vilsboll, T. Krarup, S. Madsbad, and J.J. Holst Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients Diabetologia 45 2002 1111 1119 (Pubitemid 34985287)
58. J.J. Holst, F.K. Knop, T. Vilsboll, T. Krarup, and S. Madsbad Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes Diabetes Care 34 Suppl. 2 2011 S251 S257
59. J.J. Holst Postprandial insulin secretion after gastric bypass surgery: the role of glucagon-like peptide 1 Diabetes 60 2011 2203 2205